Feb 29 |
Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024
|
Feb 23 |
BioNTech Buys Into Autolus' Cell Therapy Tech - Why I Expect A Full Acquisition In Time
|
Feb 22 |
Autolus Therapeutics announces publication in Nature Communications
|
Feb 21 |
Autolus Therapeutics plc's (NASDAQ:AUTL) institutional investors lost 8.1% last week but have benefitted from longer-term gains
|
Feb 15 |
Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year?
|
Feb 12 |
Strength Seen in Autolus Therapeutics PLC Sponsored ADR (AUTL): Can Its 6.3% Jump Turn into More Strength?
|
Feb 8 |
Autolus prices underwritten offering to raise $350M to fund development of obe-cel program
|
Feb 8 |
BioNTech to invest $200M in Autolus as part of a CAR-T deal
|
Feb 8 |
Autolus Announces Pricing of Underwritten Offering
|
Feb 8 |
BioNTech partners with Autolus to boost cell therapy manufacturing
|